Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1994-03-30
1995-03-21
Stone, Jacqueline
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
4351723, 4352402, 435 695, 435 6951, 435 6952, 935 62, 935 22, 935 32, 935 34, 935 57, 935 79, A61K 4800, C12N 522, C12N 1563, C12N 1509
Patent
active
053993462
ABSTRACT:
Primary human cells which are genetically engineered with DNA (RNA) encoding a marker or therapeutic which is expressed to be expressed in vivo. Such engineered cells may be used in gene therapy.
REFERENCES:
Siegel, Los Angeles Times, Dec. 14, 1987, "Desire to be First Colors Gene Studies" pp. 1,22-25.
Buden, The Scientist, Jan. 23, 1989, "Controversy Surrounds Gene Therapy Effort", pp. 1-3.
Siegel, Los Angeles Times, Dec. 13, 1987, "Egos, Prizes on the Line for Scientists", pp. 1, 37-40.
Anderson, John W., The Nation, Apr. 10, 1989, "Scrambling for Biotech Bucks", pp. 476-478.
Selden, N. Eng. J. Med., vol. 318, No. 20, pp. 1337-1338.
Thompson, Time, Jun. 7, 1993 "The First Kids With New Gene" pp. 50-53.
Anderson W. French
Blaese R. Michael
Rosenberg Steven A.
Lillie Raymond J.
Olstein Elliot M.
Stone Jacqueline
The United States of America as represented by the Department of
LandOfFree
Gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147385